SUPPLEMENTARY METHODS

Purified OPC cultures
OPC were obtained from neonatal mouse primary mixed glial cultures. In brief, forebrains of newborn CD1 Swiss mice were freed of meninges, chopped into 0.2-mm sections and dissociated by mild trypsinization procedure and gentle mechanical disruption with a Pasteur pipette. The cells were seeded into poly-L-lysine (10 μg/ml, Sigma-Aldrich, St. Louis, MO) coated 60 mm diameter culture dishes at the density of 1.2×10 5 cells/cm2 and grown at 37°C in a 91.5% air-8.5% CO 2 humidified atmosphere in Dulbecco's modified eagle medium (DMEM) containing 10% Foetal Bovine Serum (FBS), 2 mM glutamine and penicillin (50 μg /ml) and streptomycin (50 μg/ml), replacing fresh medium after 1 DIV and every 2-3 days (media, sera and reagents by GIBCO, Lifetechnologies, Grand Island, NY). After 8-10 days, OPC were detached from astroglia layer by mechanical dissociation; to minimize contamination by microglial cells, the detached cell suspension was incubated for 1 hour at 37°C in a 175 cm2 culture flask. The non-adering cells were seeded in the same medium as above at the density of 1 × 105 cells/cm2 into poly-L-lysine-coated dishes. Two hours after plating, culture medium was replaced with defined serum-free DMEM without thyroid hormones (56). Macrophage/microglia contamination accounted for less than 1% of total cells, as assessed by immunostaining with the monoclonal antibody (mAb) cd11b (AbD Serotec, Oxford, UK); glial fibrillary acid protein-positive astrocytes were virtually absent and the majority of cells (>99%) belonged to the OL lineage, as assessed by specific mAbs, which bind to differentiation-regulated surface antigens of these cells.
MTT reduction
One day after plating, purified OPC subcultured in 96-well microtiter plates were incubated with or without drugs (10 µM) in DMSO (0.001% vehicle) for 48 h. Measurement of reduction of [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)] was carried out as previously described (56). MTT (Sigma-Aldrich) was added to the culture medium at final concentration of 0.25 mg/ml during the final 4 h of incubation. Platelet derived growth factor (PDGF,20 ng/ml, Preprotech, Rocky Hill, NJ, USA) and tri-iodothyronin (T3, 30 ng/ml) and thyroxine (T4, 40 ng/ml) (both from Sigma-Aldrich), known to stimulate oligodendrocyte proliferation and differentiation, respectively, were used as positive controls.
[3H] Thymidine incorporation assay
Purified OPC subcultured in 96-well microtiter plates were exposed after 1 day to the compounds 
Immunohistochemistry
Cerebellar slices were incubated in the absence or presence of compounds, fixed in 4% paraformaldehyde in PBS for 10 min and then stained using double indirect immunofluorescence techniques. After washing with PBS and a blockade with 10% normal donkey serum (SigmaAldrich) in PBS for 1 h, sections were incubated overnight at 4°C with anti-neurofilament heavy chain (NFH) ( pAb (1:500, AbD Serotec) and anti-MBP mAb (clone smi99, 1:1000, Covance, Denver, PA) diluted in PBS containing 1% BSA and 0.25% Triton. Bindings were visualized using a mixture of CY3-conjugated donkey anti-rabbit IgG and fluorescein-conjugated donkey anti-mouse IgG (Jackson ImmunoResearch Laboratories, West Grove, PA) diluted in PBS+1% normal serum.
The incubation with the secondary Abs was carried out for 1 h at room temperature. Sections were then mounted in Vectashield (Vector Laboratories, Burlingame, CA) and sealed. Negative controls were performed by replacing primary antibodies with preimmune serum or IgG isotype control.
Calcium mobilization assay
HEK293mNPSR were generated as previously described (30). Cells were cultured in culture medium consisting of DMEM +10%FBS, penicillin (100 IU/ml), streptomycin (100 µg/ml), Lglutammine (2 mM), fungizone (1 µg/ml) and hygromycin B (100 µg/ml) and treated as previously 
Terminology and data analysis of calcium mobilization experiments
The pharmacological terminology adopted in calcium mobilization experiments is consistent with IUPHAR recommendations. For potency values 95% confidence limits were indicated. Maximum change in fluorescence, expressed as percent over the baseline fluorescence, was used to determine agonist response. Agonist potencies are given as pEC50 i.e. the negative logarithm to base 10 of the molar concentration of an agonist that produces 50% of the maximal effect of that agonist.
Concentration-response curves to agonists were fitted to the classical four-parameter logistic nonlinear regression model:
EC50 is the concentration of agonist producing a 50% maximal response and n is the Hill coefficient of the concentration-response curve to the agonist. Curve fitting was performed using PRISM 6.0 (GraphPad Software In., San Diego, USA).
Antagonist potencies were derived from Gaddum Schild equation:
assuming a slope value equal to unity, where CR indicates the ratio between agonist potency in the presence and absence of antagonist. 
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